Research Article: Fibrin-based microsphere reservoirs for delivery of neurotrophic factors to the brain

The Nanomedicine Special Focus Issue on ‘Engineering the nanoenvironment for regenerative medicine’ also highlights that nanobiomaterials are also increasingly being recognized for their significant potential in targeted delivery of drug payloads, and particularly for drug delivery to inaccessible anatomical or intracellular compartments. This is indicated in an original article by Juhi Samal et al. who present research on hollow fibrin microspheres and how they may be employed to protects neural growth factor activity and promote a controlled release in vivo. The authors demonstrate how these microspheres offer tuneable loading efficiency and maintaining their bioactive form after release in vivo.

Go to the profile of Nanomedicine
Apr 07, 2015
0
0
Like 0 Comment

Aim: The in vivo therapeutic potential of neurotrophic factors to modify neuronal dysfunctions is limited by their short half-life. A biomaterials-based intervention, which protects these factors and allows a controlled release, is required. Materials & methods: Hollow fibrin microspheres were fabricated by charge manipulation using polystyrene templates and were loaded with NGF. Bioactivity of released NGF was demonstrated by neuronal outgrowth assay in PC-12 cells followed by in vivo assessment for NGF release and host response. Results: Fibrin-based hollow spheres showed high loading efficiency (>80%). Neurotrophin encapsulation into the microspheres did not alter its bioactivity and controlled release of NGF was observed in the in vivo study. Conclusion: Fibrin hollow microspheres act as a suitable delivery platform for neurotrophic factors with tunable loading efficiency and maintaining their bioactive form after release in vivo.

Please visit Nanomedicine online to view the article.

Nanomedicine is also on Twitter: follow us @fsgnnm now!

Author affiliations:

Juhi Samal

Network of Excellence for Functional Biomaterials

Deirdre B Hoban

Pharmacology & Therapeutics, National University of Ireland, Galway, Ireland

Carol Naughton

Pharmacology & Therapeutics, National University of Ireland, Galway, Ireland

Ruth Concannon

Pharmacology & Therapeutics, National University of Ireland, Galway, Ireland

Eilis Dowd

Network of Excellence for Functional Biomaterials

Abhay Pandit

Network of Excellence for Functional Biomaterials

Go to the profile of Nanomedicine

Nanomedicine

Journal, Future Science Group

Nanomedicine (Impact Factor: 4.889 [2015]), is an award-winning peer-reviewed journal from Future Science Group, available in both print and online formats. Published 24 times per year, Nanomedicine is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. Nanomedicine is listed by Medline/PubMed, Science Citation Index Expanded, Journal Citation Reports/Science Edition, Current Contents/Life Sciences and the Biotechnology Citation Index. Professor Kostas Kostarelos (Nanomedicine Lab, University of Manchester, UK) and Professor Charles R Martin (University of Florida, FL, USA) are the journal’s Senior Editors. You can find out more about Nanomedicine on our website (http://www.futuremedicine.com/loi/nnm), including the journal’s aims and scope and details of our international editorial board.

No comments yet.